Cdmo Packaging Market Size and Growth
The global cdmo packaging market size reached USD 14.6 billion in 2025 and is projected to grow to USD 15.9 billion in 2026. With the expansion of pharmaceutical outsourcing and increasing demand for specialized packaging services, the market is expected to reach USD 36.8 billion by 2034, registering a CAGR of 9.8% during the forecast period (2025–2034). The cdmo packaging market is witnessing consistent growth driven by the rising outsourcing trends in the pharmaceutical and biotechnology industries. Contract Development and Manufacturing Organizations (CDMOs) are increasingly offering integrated packaging solutions to streamline drug development and commercialization processes.
One of the key growth factors in the cdmo packaging market is the increasing complexity of pharmaceutical products, particularly biologics and specialty drugs. These products require advanced packaging solutions that ensure stability, sterility, and compliance with regulatory standards. CDMOs are playing a crucial role in providing customized packaging solutions that meet these requirements.
Key Highlights:
- Market size reached USD 14.6 billion in 2025 and is projected to reach USD 36.8 billion by 2034, reflecting strong expansion driven by the growing reliance on outsourced pharmaceutical packaging services.
- The market is expected to grow at a CAGR of 9.8% during the forecast period (2025–2034), supported by increasing demand for integrated CDMO solutions and advancements in packaging technologies.
- Increasing outsourcing of pharmaceutical packaging operations is a major growth driver, as companies seek to reduce costs, improve efficiency, and accelerate time-to-market by leveraging specialized CDMO expertise.
- Rising demand for advanced and compliant packaging solutions is further fueling market growth, with innovations such as serialization, tamper-evident packaging, and cold chain solutions enhancing product safety, regulatory compliance, and supply chain transparency.
Market Trends
Integration of Serialization and Track-and-Trace Technologies
The integration of serialization and track-and-trace technologies is a significant trend in the cdmo packaging market. Regulatory requirements for drug traceability are increasing across regions, prompting CDMOs to adopt advanced serialization systems. These technologies enable unique identification of pharmaceutical products, improving supply chain visibility and reducing the risk of counterfeit drugs. CDMOs are investing in digital infrastructure to support serialization, including data management systems and automated packaging lines. This trend is expected to strengthen compliance and enhance operational efficiency across the pharmaceutical supply chain.
Growth of Biologics and Specialized Drug Packaging
The growth of biologics and specialized drug packaging is another key trend shaping the market. Biologics require strict temperature control and protection from environmental factors, necessitating advanced packaging solutions. CDMOs are developing specialized packaging formats such as prefilled syringes, vials, and cold chain packaging systems. This trend is driving innovation in materials and technologies, supporting market growth.
Market Drivers
Increasing Outsourcing by Pharmaceutical Companies
The increasing outsourcing of packaging operations by pharmaceutical companies is a major driver of the cdmo packaging market. Companies are focusing on reducing costs and improving efficiency by partnering with CDMOs. Outsourcing allows pharmaceutical firms to leverage the expertise and infrastructure of CDMOs, enabling faster time-to-market. This trend is particularly beneficial for small and mid-sized companies, supporting market growth.
Rising Demand for Complex and Biologic Drug Packaging
The rising demand for complex and biologic drug packaging is another key driver of the market. Biologic drugs require specialized packaging solutions that ensure stability and sterility. CDMOs are offering customized packaging services to meet these requirements. The increasing prevalence of chronic diseases and demand for advanced therapies are driving the adoption of biologics, supporting market growth.
Market Restraint
Stringent Regulatory Requirements and Compliance Costs
Stringent regulatory requirements and compliance costs present a significant restraint for the cdmo packaging market. Pharmaceutical packaging must comply with strict guidelines related to labeling, safety, and traceability. Meeting these requirements often involves high costs associated with equipment, validation, and documentation. For example, implementing serialization systems requires significant investment in technology and infrastructure. Smaller CDMOs may face challenges in meeting these requirements, limiting market growth. Additionally, frequent changes in regulations can increase operational complexity and costs.
Market Opportunities
Expansion of CDMO Services in Emerging Markets
The expansion of CDMO services in emerging markets presents a significant opportunity for the cdmo packaging market. Regions such as Asia Pacific and Latin America are witnessing rapid growth in pharmaceutical manufacturing. Increasing healthcare expenditure and supportive government initiatives are driving the demand for CDMO services. Companies can capitalize on this opportunity by expanding their presence and offering cost-effective packaging solutions.
Adoption of Sustainable Packaging Solutions
The adoption of sustainable packaging solutions offers another key opportunity for the market. Pharmaceutical companies are increasingly focusing on reducing environmental impact by using recyclable and biodegradable materials. CDMOs are investing in sustainable packaging technologies to meet this demand. This trend is expected to drive innovation and create new growth opportunities.
Segmental Analysis
By Packaging Type
The primary packaging segment dominated the cdmo packaging market in 2024, accounting for approximately 57% of the total market share. This dominance is attributed to its direct contact with pharmaceutical products, requiring high-quality materials and stringent compliance standards. Primary packaging includes bottles, vials, blister packs, and prefilled syringes. The increasing demand for biologics and injectable drugs is driving the growth of this segment, as these products require advanced packaging solutions to maintain stability and sterility.
The secondary packaging segment is expected to be the fastest-growing, with a projected CAGR of 10.1% during the forecast period. This growth is driven by increasing demand for labeling, branding, and product protection. Secondary packaging plays a crucial role in ensuring product safety during transportation and storage. The adoption of advanced printing and labeling technologies is further supporting segment growth.
By Service Type
The packaging design and development segment held the largest market share in 2024, accounting for approximately 45% of the total revenue. CDMOs are offering comprehensive design services to meet the specific requirements of pharmaceutical companies. These services include material selection, structural design, and regulatory compliance. The increasing complexity of pharmaceutical products is driving demand for customized packaging solutions, supporting segment growth.
The labeling and serialization segment is expected to be the fastest-growing, with a CAGR of 10.3% during the forecast period. This growth is driven by stringent regulatory requirements for product traceability and anti-counterfeiting measures. CDMOs are investing in advanced labeling technologies to meet these requirements.
By End-Use
The pharmaceutical companies segment dominated the market in 2024, accounting for approximately 60% of the total share. Pharmaceutical companies are increasingly outsourcing packaging operations to CDMOs to reduce costs and improve efficiency. The growing demand for advanced therapies is driving the adoption of CDMO services.
The biotechnology companies segment is expected to be the fastest-growing, with a CAGR of 10.4% during the forecast period. This growth is driven by increasing demand for biologics and specialized drug packaging solutions. Biotechnology companies are relying on CDMOs to provide advanced packaging services, supporting market growth.
| Packaging Type | Service Type | End-Use |
|---|---|---|
|
|
|
Regional Analysis
North America
North America accounted for approximately 40% of the cdmo packaging market share in 2025 and is expected to grow at a CAGR of 9.2% during the forecast period. The region’s growth is driven by a strong pharmaceutical industry and increasing outsourcing trends. The presence of advanced healthcare infrastructure supports market expansion.
The United States dominates the North American market due to its well-established pharmaceutical sector. A unique growth factor is the high adoption of serialization technologies, which enhances product traceability and compliance with regulatory standards.
Europe
Europe held a market share of approximately 25% in 2025 and is projected to grow at a CAGR of 9.5% during the forecast period. The region’s growth is driven by stringent regulatory requirements and increasing demand for advanced packaging solutions.
Germany is the dominant country in the European market, supported by its strong pharmaceutical manufacturing base. A unique growth factor is the focus on sustainable packaging solutions, driving demand for eco-friendly materials.
Asia Pacific
Asia Pacific accounted for around 23% of the global market share in 2025 and is expected to register the highest CAGR of 10.5% during the forecast period. The region’s growth is driven by increasing pharmaceutical manufacturing and outsourcing activities.
China is the leading country in the Asia Pacific market due to its large manufacturing base. A unique growth factor is the expansion of CDMO services, supporting market growth.
Middle East & Africa
The Middle East & Africa region held a market share of approximately 6% in 2025 and is expected to grow at a CAGR of 8.4% during the forecast period. The market is driven by improving healthcare infrastructure and increasing demand for pharmaceutical products.
The United Arab Emirates is a key market in the region, driven by its growing healthcare sector. A unique growth factor is the increasing adoption of advanced packaging technologies.
Latin America
Latin America accounted for around 6% of the global market share in 2025 and is projected to grow at a CAGR of 8.7% during the forecast period. The region’s growth is supported by increasing pharmaceutical manufacturing and outsourcing trends.
Brazil is the dominant country in the Latin American market due to its large consumer base. A unique growth factor is the expansion of the pharmaceutical industry, driving demand for CDMO packaging services.
| North America | Europe | APAC | Middle East and Africa | LATAM |
|---|---|---|---|---|
|
|
|
|
|
Competitive Landscape
The cdmo packaging market is characterized by strong competition, with key players focusing on expanding service offerings and enhancing technological capabilities. Companies are investing in advanced packaging technologies to meet evolving industry requirements. Strategic partnerships and acquisitions are common as players aim to strengthen their market position.
Catalent, Inc. is considered a leading player in the market due to its comprehensive service portfolio and global presence. The company recently expanded its packaging capabilities to include advanced serialization and cold chain solutions. Other key players are also focusing on sustainability and digitalization to gain a competitive edge.
Key Players List
- Catalent, Inc.
- Lonza Group AG
- Thermo Fisher Scientific Inc.
- Recipharm AB
- Samsung Biologics
- Almac Group
- Jubilant HollisterStier LLC
- Piramal Pharma Solutions
- AbbVie Contract Manufacturing
- Vetter Pharma International
- Boehringer Ingelheim BioXcellence
- Famar Group
- Siegfried Holding AG
- CordenPharma International
- Aenova Group